Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA: Canada Impact+ Research Training Awards - Doctoral

University of Toronto

$120,000.00

Monoamine oxidase functions during cardiometabolic disease

FY 2025-26

Summary
"Background: Roughly 20% of Canadians currently live with cardiometabolic diseases that include obesity, type 1 or type 2 diabetes or metabolic syndrome, which place people at extra risk for co-morbidities like heart and neurodegenerative diseases. In fact, ~15% of the population reports having 2+ of these conditions. Finding new targets at the interface of cardio-, neuro- and metabolic diseases continues to be critically important. We are interested in studying the monoamine oxidase enzyme family (MAOs), as they are expressed in nutrient and stress-sensitive organs, including the brain and gut; plus liver, muscle, heart, adipose tissue and pancreas. There are 3 MAOs: A, B and C; the latter is commonly called “Renalase”. Original studies regarding MAO-A and -B showed strong associations with neurological conditions. More recent work shows an emerging association between Renalase and diabetes. Renalase intersects with multiple diseases, but the major outstanding questions about its biological roles are: is Renalase a cause or consequence of metabolic disease, and/or is it a viable drug target? Hypothesis: At the whole-body level, we suspect that Renalase increases in response to nutrient overload and stress. At the cellular level, the basic biology of Renalase is almost entirely unknown but we hypothesize that it is impacted by high glucose/high fat. Target tissues of interest are the brain, gut and pancreas given their essential roles in glucose homeostasis Methods: Using animal models of diet and drug-induced diabetes, plus genetic animal models, we will track the appearance of Renalase in the blood and relevant organs alongside thorough metabolic testing. Multiple cell types (i.e brain, pancreatic beta cells) will be cultured in the lab to determine molecular factors that control Renalase biology. Outcomes: We will determine whether Renalase is a cause or consequence of diabetes, so that future work can develop better therapeutic strategies. "
Program
DRA: Canada Impact+ Research Training Awards - Doctoral
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
568318
Name
Bu Tiange
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Canada Impact+ Research Training Awards - Doctoral
Projecttitle
Monoamine oxidase functions during cardiometabolic disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA: Canada Impact+ Research Training Awards - Doctoral
Keyworddelim
Metabolism; Neurodegeneration; Animal Models; Biochemistry; Cells; Diabetes; Enzymes; Heart Disease
Abstract
"Background: Roughly 20% of Canadians currently live with cardiometabolic diseases that include obesity, type 1 or type 2 diabetes or metabolic syndrome, which place people at extra risk for co-morbidities like heart and neurodegenerative diseases. In fact, ~15% of the population reports having 2+ of these conditions. Finding new targets at the interface of cardio-, neuro- and metabolic diseases continues to be critically important. We are interested in studying the monoamine oxidase enzyme family (MAOs), as they are expressed in nutrient and stress-sensitive organs, including the brain and gut; plus liver, muscle, heart, adipose tissue and pancreas. There are 3 MAOs: A, B and C; the latter is commonly called “Renalase”. Original studies regarding MAO-A and -B showed strong associations with neurological conditions. More recent work shows an emerging association between Renalase and diabetes. Renalase intersects with multiple diseases, but the major outstanding questions about its biological roles are: is Renalase a cause or consequence of metabolic disease, and/or is it a viable drug target? Hypothesis: At the whole-body level, we suspect that Renalase increases in response to nutrient overload and stress. At the cellular level, the basic biology of Renalase is almost entirely unknown but we hypothesize that it is impacted by high glucose/high fat. Target tissues of interest are the brain, gut and pancreas given their essential roles in glucose homeostasis Methods: Using animal models of diet and drug-induced diabetes, plus genetic animal models, we will track the appearance of Renalase in the blood and relevant organs alongside thorough metabolic testing. Multiple cell types (i.e brain, pancreatic beta cells) will be cultured in the lab to determine molecular factors that control Renalase biology. Outcomes: We will determine whether Renalase is a cause or consequence of diabetes, so that future work can develop better therapeutic strategies. "
Competitiondate
202603
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bu, Tiange
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~